Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a

Multiple Sclerosis

Volumn 10, Issue 1, 2004, Pages 85-86

  Kumar, Neeraj ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

Interferons; Monoclonal antibodies; Multiple sclerosis; Scleromyxedema

Indexed keywords

BETA1A INTERFERON; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN LAMBDA CHAIN; MUCIN; MYELIN; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MUCINOSIS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; REMYELINIZATION; SCLEROMYXEDEMA; SKIN DISEASE; SKIN INJURY;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-BETA; LICHENOID ERUPTIONS; MULTIPLE SCLEROSIS; MYXEDEMA; PARAPROTEINEMIAS;

EID: 0346076580     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms987cr     Document Type: Article

References (7)

1. Benito-León J, Borbujo J, Cortés L. Cutaneous mucinoses complicating interferon beta-1b therapy. Eur Neurol 2002; 47: 123-24.
2. Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum. J Am Acad Dermatol 1997; 37: 553-58.
3. Arnason BGW, Reder AT. Interferons and multiple sclerosis. Clin Neuropharmacol 1994; 17: 495-547.
4. Berger JR, Dobbs MR, Terhune MH, Maragos WF. The neurologic complications of scleromyxedema. Medicine 2001; 80: 313-19.
5. Johkura K, Susuki K, Hasegawa O, Kuroiwa Y, Komatsumoto S. Encephalopathy in scleromyxedema. Neurology 1999; 53: 1138-40.
6. Kantor GR, Bergfeld WF, Katzin WE, Reynolds OD et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14: 879-88.
7. 2+ influx pathways in astrocytes and oligodendrocytes: Relationship to the mechanism of myelin repair. Mol Cell Neurosci 2003; 22: 14-24.